Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study

OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are the cornerstone of treatment of major depressive disorder (MDD). However, non-response is common, often necessitating combination strategies. The present study assessed the efficacy of vortioxetine as an add-on therapy in patients with S...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Braz J Psychiatry
Main Authors: De Berardis, Domenico, Fornaro, Michele, Anastasia, Annalisa, Vellante, Federica, Olivieri, Luigi, Rapini, Gabriella, Serroni, Nicola, Orsolini, Laura, Valchera, Alessandro, Carano, Alessandro, Tomasetti, Carmine, Ventriglio, Antonio, Bustini, Massimiliano, Pompili, Maurizio, Serafini, Gianluca, Perna, Giampaolo, Iasevoli, Felice, Martinotti, Giovanni, Di Giannantonio, Massimo
Formato: Artigo
Idioma:Inglês
Publicado: Associação Brasileira de Psiquiatria 2020
Assuntos:
Brief Communication
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7236167/
https://ncbi.nlm.nih.gov/pubmed/32159712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/1516-4446-2019-0690
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares